White House Patent Plan To Curb Drug Prices Draws Outcry
A Biden administration proposal aiming to lower drug prices by using the government's authority to override patents for products developed with federal funding has drawn fierce pushback from drugmakers, universities and...To view the full article, register now.
Already a subscriber? Click here to view full article